Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Emission: Bli delägare i Alice & Nilda – Nytänkande proteinbolag i outnyttjad snabbväxande marknad (annons)

Senaste aktieanalyserna

►
Analys | Redeye
 • Igår 15:21

Careium: Interim CEO appointed - Redeye

Careium
Analys | Redeye
 • Igår 10:34

Netmore Group: Major deal with a Swedish property developer - Redeye

Redeye is encouraged by Netmore’s agreement with a Swedish property developer, potentially worth SEK...

Netmore
Analys | Nordea
 • Igår 10:34

NoHo: The company raises its guidance again given good demand and outlook for the reminder of the year - Nordea

NoHo Partners
Analys | Redeye
 • Igår 09:30

Safeture: Comment on the rights issue - Redeye

Redeye comments on Safeture’s rights issue, which will give the company the needed capital to bridge...

Safeture
Analys | Nordea
 • Igår 09:30

Etteplan: Semcon acquisition failed - Nordea

Etteplan
Analys | Redeye
 • Igår 08:34

Remedy: Discounted premium growth - Redeye

Redeye lowers its expectations and valuation on Remedy.

Remedy Entertainment
Analys | ABG Sundal Collier
 • Igår 07:39

Christian Berner Tech Trade: Component shortages weigh on margins - ABG

Christian Berner Tech
Analys | Redeye
 • Igår 07:38

Saniona: Amended Loan Agreement - Redeye

Redeye is overall positive to today’s news that Saniona has amended its loan agreement with Formue N...

Saniona
Analys | Redeye
 • 30 Sep 15:11

Scandion Oncology: Our comment on CORIST part 2 top-line data - Redeye

Scandion Oncology
Analys | Redeye
 • 30 Sep 14:14

Seamless Distribution Systems: Largest deal yet - Redeye

Redeye is encouraged by SDS’s business momentum, announcing its largest agreement yet.

Seamless Distribution Systems
Analys | ABG Sundal Collier
 • 30 Sep 14:14

Christian Berner: Component shortages weigh on margins - ABG

Christian Berner Tech
Analys | Redeye
 • 30 Sep 14:12

Cereno Scientific: Announces outcome of the warrants of series TO2 - Redeye

Redeye comments on the outcome of Cereno Scientific’s warrants of series TO2.

Cereno Scientific
Analys | ABG Sundal Collier
 • 30 Sep 13:13

Alcadon: Taking a closer look at “Vision 2025” - ABG

Alcadon Group
Analys | ABG Sundal Collier
 • 30 Sep 12:56

Dedicare: Enters UK via acquisition - ABG

Acquires Templars Medical Agency Ltd. Sees it as a platform to build from in UK and Ireland Dedica...

Dedicare
Analys | Evli
 • 30 Sep 12:02

Endomines: Reverse share split - Evli

Endomines
Analys | Redeye
 • 30 Sep 11:57

Alligator Bioscience: 900mg reached with ATOR-1017 - Redeye

Redeye comments on Alligator’s successful conclusion of the phase I trial with ATOR-1017.

Alligator Bioscience
Analys | Penser
 • 30 Sep 11:42

Fingerprint Cards: Planerar genomföra nyemission på 300 mkr - Penser

Fingerprint Cards
Analys | Redeye
 • 30 Sep 11:14

Enea: New 5G Order and Updated Q3 Estimates - Redeye

Redeye raises its estimates following today’s 5G deal for Enea.

Enea
Analys | Redeye
 • 30 Sep 10:39

Inhalation Sciences: High Sales Activity - Redeye

Inhalation Sciences
Analys | Redeye
 • 30 Sep 07:37

Sivers Semiconductors: Short-Term Financing Need Solved - Redeye

Redeye is optimistic about Sivers’ debt financing, whose terms are good considering the current mark...

Sivers Semiconductors
Analys | Kalqyl
 • 30 Sep 07:36

Calmark: Tillväxtresan kan starta - Kalqyl

Calmark
Analys | Redeye
 • 29 Sep 15:30

XMReality: Solid order from long-term customer ABB - Redeye

Redeye is encouraged by XMReality’s latest order from ABB as it validates XMReality’s growth strateg...

XMReality
Analys | Redeye
 • 29 Sep 09:30

Truecaller: Comment on Viceroy Short-Seller Report - Redeye

Truecaller
Analys | Redeye
 • 29 Sep 08:58

BioArctic: Lecanemab i tydlig ledning - Redeye

Redeye återkommer med sin syn på BioArctic efter de transformativa och tydligt positiva fas III-resu...

BioArctic
Analys | Redeye
 • 29 Sep 08:01

Netmore Group: High-volume IoT breakthrough - Redeye

Netmore
Analys | Analyst Group
 • 28 Sep 13:37

Analyst Group kommenterar AcuCorts godkännande i Norge och positiva enkätstudieresultat

AcuCort tillkännagav den 28:e september att bolaget har erhållit godkännande av den norska läkemedel...

AcuCort
Analys | ABG Sundal Collier
 • 28 Sep 09:18

Alcadon: New ambitious financial targets - ABG

Alcadon Group
Analys | Redeye
 • 28 Sep 09:17

BioArctic: Fantastiska nyheter - Redeye

Redeye är mycket positiva till nattens tydligt positiva top-line data från fas III-studien ”Clarity ...

BioArctic
Analys | Redeye
 • 28 Sep 07:51

Alelion: Record-Breaking Order of SEK 130m! - Redeye

Alelion Energy
Analys | Redeye
 • 28 Sep 07:51

Acuvi: Capital Markets Day - Redeye

Redeye yesterday attended Acuvi’s first Capital Markets Day.

Acuvi